← All projects
Organ repair and replacement

BiVACOR total artificial heart

BiVACOR

This could keep someone alive and healthier when an organ is failing by repairing it, supporting it or replacing it.

WHAT IT IS TRYING TO CHANGE

What the project is doing

BiVACOR total artificial heart is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

This could keep someone alive and healthier when an organ is failing by repairing it, supporting it or replacing it.

What has to happen next

The next checkpoint is whether the treatment is safe enough and shows enough biological activity to continue.

What could stop it

The study is mainly about safety and dose. It may not show whether people actually live longer or feel better.

WHERE IT STANDS

Current evidence and outlook

BiVACOR total artificial heart is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Often 5–10 years from broad availability, if safety and later studies succeed.

Why this estimate

Early human testing answers only part of what is needed.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. BiVACOR — current first-in-human study
  2. BiVACOR — five patients and FDA study expansion
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check